Protective isolation for prevention of fection in patients with severely decreased resistance.
D000380:Agranulocytosis / Q000276:immunology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D004352:Drug Resistance, Microbial; D006801:Humans; D017053:Infection Control; D010356:Patient Isolation
D000900:Anti-Bacterial Agents